POPULATION BASED GENETIC TESTING FOR HIGH-RISK BREAST AND OVARIAN CANCER PREDISPOSITION GENES
Grant number: 1126679 | Funding period: 2017 - 2020
Inherited mutations in BRCA1 and BRCA2 confer a very high risk of breast and ovarian cancer. Importantly, once carriers are identified, effective strategies are available that can dramatically reduce the risk of cancer. We will perform genetic testing of a healthy western population to identify breast/ovarian cancer genes before the women develop cancer. Population-based screening could significantly reduce the incidence of these diseases.